SynthesisRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2018
Exposure of the lungs in breast cancer radiotherapy: A systematic review of lung doses published 2010-2015.
Synthesis in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
69 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Estimated Doses to the Heart, Lungs and Oesophagus and Risks From Typical UK Radiotherapy for Early Breast Cancer During 2015-2023.Clinical oncology (Royal College of Radiologists (Great Britain)) · 2024Pooled it
- Proton Beam Therapy for Early Breast Cancer: A Systematic Review and Meta-analysis of Clinical Outcomes.International journal of radiation oncology, biology, physics · 2023Pooled it
- Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortality.Cancer treatment reviews · 2022Pooled it
- Trial
- Deep-inspirational breath-hold (DIBH) technique in left-sided breast cancer: various aspects of clinical utility.Radiation oncology (London, England) · 2021Trial
- The impact of effective dose to the immune cells on survival in breast cancer patients.Clinical and translational radiation oncology · 2026Article
- Influence of target coverage priority levels on dose homogeneity in commercial automated field-in-field planning for breast radiotherapy.Radiological physics and technology · 2026Article
- Dosimetric comparison of organs at risk exposure in multicatheter high-dose-rate interstitial brachytherapy vs. VMAT-based APBI for real patient treatment plans.Journal of contemporary brachytherapy · 2026Article
- Volume ratio factor: a novel CT-derived biomarker for pre-planning ipsilateral lung dose risk stratification in breast cancer radiotherapy.Quantitative imaging in medicine and surgery · 2026Article
- Organ at risk sparing by non-coplanar prone breast radiotherapy on Halcyon/Ethos linacs utilizing breast couch slewing.Scientific reports · 2026Article
- Characterization of dosimetric predictors for pulmonary perfusion changes before and after hypofractionated whole-breast radiotherapy in node-negative breast cancer patients: A prospective study.Journal of applied clinical medical physics · 2026Article
- Optimizing Radiotherapy for Left Breast Cancer: A Dosimetric Evaluation of Hypofractionated vs. Conventional VMAT with DIBH.Asian Pacific journal of cancer prevention : APJCP · 2026Article
- Integrating static angle ports and dynamic collimator rotation in volumetric modulated arc therapy for hypofractionated whole breast irradiation in Chinese females: a single-centre dosimetric study.Radiation oncology (London, England) · 2026Article
- Cost-Effectiveness of Proton Therapy Compared With Photon Therapy in Breast Cancer.JAMA network open · 2026Article
- Improvement of Dosimetry Planning in 3D Conformal Radiotherapy for Breast Cancer With Lymph Nodes Using the High-Tangential Tilted-Supraclavicular Technique.International journal of breast cancer · 2026Article
- Risk prediction model for radiation pneumonitis in breast cancer radiotherapy based on dose-volume parameters combined with the neutrophil-to-lymphocyte ratio.Frontiers in oncology · 2026Article
- Deep inspiration breath-hold for breast cancer radiotherapy: a modelling study of targeted versus non-targeted strategy for clinical and operational optimisation.The Lancet regional health. Europe · 2026Article
- NTCP-Based Prediction of Lung Sparing With IMPT in BC Patients and Implication of Patient Selection.International journal of particle therapy · 2025Article
- Standard operating procedure (SOP) for immobilisation, scanning, verification and treatment of breast cancer patients undergoing proton beam therapy.Technical innovations & patient support in radiation oncology · 2025Article
- The Effect of Resistance Training on Serum Levels of Lipid Profile and Liver Enzymes in Male Rat Undergoing Radiotherapy.Asian Pacific journal of cancer prevention : APJCP · 2025Article
9 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
background and purposeWe report a systematic review of lung radiation doses from breast cancer radiotherapy. METHODS AND MATERIALS: Studies describing breast cancer radiotherapy regimens published during 2010-2015 and reporting lung dose were included. Doses were compared between different countries, anatomical regions irradiated, techniques and use of breathing adaptation.
results471 regimens from 32 countries were identified. The average mean ipsilateral lung dose (MLD
conclusionsLung doses from breast cancer radiotherapy varied substantially worldwide, even between studies describing similar regimens. Lymph node inclusion and IMRT use increased exposure, while breathing adaptation and prone/lateral decubitus positioning reduced it.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.